Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

Press Releases

All Releases
View Summary OPKO Investee Zebra Biologics Announces Collaboration with AbbVie to Discover New Antibody Therapeutics
Jan 10, 2017
PDF 17.5 KB
View Summary OPKO Announces Initiation of Claros® 1 Clinical Trial for Total PSA
Jan 9, 2017
PDF 16.6 KB
View Summary OPKO Health to Present at the J.P. Morgan 35th Annual Healthcare Conference
Jan 4, 2017
PDF 14.1 KB
View Summary OPKO Health Provides Update on hGH-CTP Clinical Programs
Dec 30, 2016
PDF 18.6 KB
View Summary OPKO Health to be Added to the NASDAQ Biotechnology Index
Dec 19, 2016
PDF 16.2 KB
View Summary OPKO Health to Participate at Three Investment Conferences in December
Nov 30, 2016
PDF 16.3 KB
View Summary OPKO Announces U.S. Launch of RAYALDEE™
Nov 23, 2016
PDF 67.8 KB
View Summary OPKO Presents Data on RAYALDEE® at ASN Kidney Week 2016
Nov 17, 2016
PDF 64.6 KB
View Summary OPKO Health Reports Third Quarter Financial and Operating Results
Nov 7, 2016
PDF 35.9 KB
View Summary OPKO to Announce Third Quarter Operating and Financial Results on November 7, 2016
Nov 3, 2016
PDF 15.0 KB
View Summary OPKO Health Enters Companion Animal Health Market
Oct 27, 2016
PDF 15.9 KB
View Summary OPKO Health Appoints Dr. Benjamin Solomon as Managing Director of GeneDx
Sep 27, 2016
PDF 14.6 KB
View Summary OPKO Health to Present at the Ladenburg Thalmann 2016 Healthcare Conference
Sep 19, 2016
PDF 11.1 KB
View Summary OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories
Sep 13, 2016
PDF 15.2 KB
View Summary OPKO to Present Long-acting Human Growth Hormone (hGH-CTP) Phase 2 Pediatric Growth Hormone Deficiency Data at the 55th Annual Meeting of the European Society for Paediatric Endocrinology
Sep 6, 2016
PDF 21.7 KB
View Summary OPKO Health to Participate in Upcoming September Conferences
Sep 1, 2016
PDF 14.3 KB
View Summary OPKO Health Completes Acquisition of Transition Therapeutics
Aug 31, 2016
PDF 14.7 KB
View Summary Transition Therapeutics Shareholders Approve Acquisition by OPKO Health
Aug 26, 2016
PDF 14.5 KB
View Summary OPKO Health Responds to Law Firm Notice of Investigation
Aug 23, 2016
PDF 13.1 KB
View Summary OPKO Health Reports Improved Financial and Operating Results
Aug 8, 2016
PDF 29.9 KB
Showing 1-20 of 309 Page: 1 2 3 4 5 ... 16  Next 20

Email  Sign up for email alerts